These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23139382)

  • 21. SPR-based fragment screening: advantages and applications.
    Neumann T; Junker HD; Schmidt K; Sekul R
    Curr Top Med Chem; 2007; 7(16):1630-42. PubMed ID: 17979772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Progress in the fragment-based drug discovery].
    Ren J; Li J; Shi F; Wang X; He JH; Xu YC; Zhang NX; Xiong B; Shen JK
    Yao Xue Xue Bao; 2013 Jan; 48(1):14-24. PubMed ID: 23600136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. X-ray and molecular modelling in fragment-based design of three small quinoline scaffolds for HIV integrase inhibitors.
    Majerz-Maniecka K; Musiol R; Skórska-Stania A; Tabak D; Mazur P; Oleksyn BJ; Polanski J
    Bioorg Med Chem; 2011 Mar; 19(5):1606-12. PubMed ID: 21316973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental validation of a fragment library for lead discovery using SPR biosensor technology.
    Elinder M; Geitmann M; Gossas T; Källblad P; Winquist J; Nordström H; Hämäläinen M; Danielson UH
    J Biomol Screen; 2011 Jan; 16(1):15-25. PubMed ID: 21149860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective progression of nuclear magnetic resonance-detected fragment hits.
    Eaton HL; Wyss DF
    Methods Enzymol; 2011; 493():447-68. PubMed ID: 21371601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for antiviral inhibitors of the HIV integrase-LEDGF/p75 interaction using the AlphaScreen luminescent proximity assay.
    Hou Y; McGuinness DE; Prongay AJ; Feld B; Ingravallo P; Ogert RA; Lunn CA; Howe JA
    J Biomol Screen; 2008 Jun; 13(5):406-14. PubMed ID: 18480474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation.
    Ward RA; Brassington C; Breeze AL; Caputo A; Critchlow S; Davies G; Goodwin L; Hassall G; Greenwood R; Holdgate GA; Mrosek M; Norman RA; Pearson S; Tart J; Tucker JA; Vogtherr M; Whittaker D; Wingfield J; Winter J; Hudson K
    J Med Chem; 2012 Apr; 55(7):3285-306. PubMed ID: 22417091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combining NMR and X-ray crystallography in fragment-based drug discovery: discovery of highly potent and selective BACE-1 inhibitors.
    Wyss DF; Wang YS; Eaton HL; Strickland C; Voigt JH; Zhu Z; Stamford AW
    Top Curr Chem; 2012; 317():83-114. PubMed ID: 21647837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining biophysical screening and X-ray crystallography for fragment-based drug discovery.
    Hennig M; Ruf A; Huber W
    Top Curr Chem; 2012; 317():115-43. PubMed ID: 21837555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: influence of the alkylation of position 4.
    Billamboz M; Bailly F; Lion C; Calmels C; Andréola ML; Witvrouw M; Christ F; Debyser Z; De Luca L; Chimirri A; Cotelle P
    Eur J Med Chem; 2011 Feb; 46(2):535-46. PubMed ID: 21185110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-guided fragment screening for lead discovery.
    Verdonk ML; Hartshorn MJ
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):404-10. PubMed ID: 15338949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and generation of highly diverse fluorinated fragment libraries and their efficient screening with improved (19) F NMR methodology.
    Vulpetti A; Dalvit C
    ChemMedChem; 2013 Dec; 8(12):2057-69. PubMed ID: 24127294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hsp90 inhibitors and drugs from fragment and virtual screening.
    Roughley S; Wright L; Brough P; Massey A; Hubbard RE
    Top Curr Chem; 2012; 317():61-82. PubMed ID: 21647838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electron density guided fragment-based drug design--a lead generation example.
    Abad MC; Gibbs AC; Zhang X
    Methods Enzymol; 2011; 493():487-508. PubMed ID: 21371603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fragment based drug discovery: practical implementation based on ¹⁹F NMR spectroscopy.
    Jordan JB; Poppe L; Xia X; Cheng AC; Sun Y; Michelsen K; Eastwood H; Schnier PD; Nixey T; Zhong W
    J Med Chem; 2012 Jan; 55(2):678-87. PubMed ID: 22165820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of novel HIV-1 integrase inhibitors using shape-based screening, QSAR, and docking approach.
    Gupta P; Garg P; Roy N
    Chem Biol Drug Des; 2012 May; 79(5):835-49. PubMed ID: 22233531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of a small-molecule HIV-1 integrase inhibitor-binding site.
    Al-Mawsawi LQ; Fikkert V; Dayam R; Witvrouw M; Burke TR; Borchers CH; Neamati N
    Proc Natl Acad Sci U S A; 2006 Jun; 103(26):10080-5. PubMed ID: 16785440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tn5 transposase as a useful platform to simulate HIV-1 integrase inhibitor binding mode.
    Barreca ML; Ortuso F; Iraci N; De Luca L; Alcaro S; Chimirri A
    Biochem Biophys Res Commun; 2007 Nov; 363(3):554-60. PubMed ID: 17889829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Native State Mass Spectrometry, Surface Plasmon Resonance, and X-ray Crystallography Correlate Strongly as a Fragment Screening Combination.
    Woods LA; Dolezal O; Ren B; Ryan JH; Peat TS; Poulsen SA
    J Med Chem; 2016 Mar; 59(5):2192-204. PubMed ID: 26882437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homogeneous high-throughput screening assays for HIV-1 integrase 3beta-processing and strand transfer activities.
    Wang Y; Klock H; Yin H; Wolff K; Bieza K; Niswonger K; Matzen J; Gunderson D; Hale J; Lesley S; Kuhen K; Caldwell J; Brinker A
    J Biomol Screen; 2005 Aug; 10(5):456-62. PubMed ID: 16093555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.